Sorafenib(LuciSora)

Release date: 2026-10-21 14:00:46     Recommended: 2

Indicated for the treatment of unresectable hepatocellular carcinoma, advanced renal cell carcinoma, and progressive differentiated thyroid cancer that is refractory to radioactive iodine therapy.